Abstract
Kynurenine pathway inhibition reverses deficits in Alzheimer's mouse models.
MeSH terms
-
Alzheimer Disease* / drug therapy
-
Alzheimer Disease* / metabolism
-
Amyloid beta-Peptides / metabolism
-
Animals
-
Disease Models, Animal
-
Humans
-
Indoleamine-Pyrrole 2,3,-Dioxygenase* / metabolism
-
Kynurenine* / metabolism
-
Mice
-
Tryptophan / metabolism
Substances
-
Amyloid beta-Peptides
-
IDO1 protein, mouse
-
Indoleamine-Pyrrole 2,3,-Dioxygenase
-
Kynurenine
-
Tryptophan